News and Opinion

Antibiotic Resistance Funding Bump

The newly approved US budget includes a doubling of funding for combating antibiotic resistance.
Published in Microbiology
Go to the profile of Michael Chao
Michael Chao
Project Manager, Harvard TH Chan School of Public Health
Antibiotic Resistance Funding Bump
Like
Go to the profile of Yanling Wang
Go to the profile of April Pawluk

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Alright, everyone. Get your word processors fired up and biosketches up to date because we're anticipating open season on antibiotic resistance funding this year.

Last month, to the relief of many, US Congress passed a 2016 budget bill which included a 6.6% increase in funding for the National Institutes of Health, the largest increase since 2003. One of the major beneficiaries of the bump are scientists working on antibiotic resistance, with the White House previously announcing its intention to put 1.2 billion dollars into this field, nearly doubling current funding levels.

And just yesterday, NIH-NIAID announced the awarding of 5 million dollars in funding for 24 grants investigating alternative, non-antibiotic based therapies to combat the growing problem of super resistant infections.

Here's hoping the funding push gains momentum because we certainly need more creative solutions if we're going to prevent ourselves from tumbling back into the pre-antibiotic era.


Go to the profile of Michael Chao
Michael Chao
Project Manager, Harvard TH Chan School of Public Health
I first developed an interest in bacterial pathogenesis while at Cornell University. I then earned my PhD in Biomedical and Biological Sciences from Harvard University in Eric Rubin’s laboratory, studying cell wall remodelling in Mycobacterium tuberculosis. From 2012-2015, I continued my training as a postdoctoral fellow in Matthew Waldor’s lab at Harvard Medical School, investigating the role of DNA methylation on regulating fundamental cellular processes in Vibrio cholerae.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.